Financing Extends Runway and Supports Continued Advancement of Atopic Dermatitis (Eczema) and Onychomycosis (Nail Fungus) Programs LOS ANGELES–(BUSINESS WIRE)–Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage dermatology company developing novel therapies for inflammatory skin diseases, today…
LOS ANGELES–(BUSINESS WIRE)–Turn Therapeutics, a clinical-stage biotechnology company pioneering next-generation topical therapies, today announced the launch of its final crowdfund investment round in tandem with the upcoming initiation of a controlled clinical trial evaluating its flagship, non-steroidal…
December 12, 2024 09:00 AM Eastern Standard Time WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–Turn Therapeutics, an innovator in advanced wound and dermatology solutions, is pleased to announce a significant investment commitment from GEM Global Yield LLC SCS…